Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.7K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

116
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
116
Radiation: Applications01:17

Radiation: Applications

1.6K
The average temperature of Earth is the subject of much current discussion. Earth is in radiative contact with both the Sun and dark space; it receives almost all its energy from the radiation of the Sun and reflects some of it into outer space. Dark space is very cold, about 3 K, so Earth radiates energy into it. For instance, heat transfer occurs from soil and grasses, the rate of which can be so rapid that frost can occur on clear summer evenings, even in warm latitudes.
The average...
1.6K
Cancer Therapies02:49

Cancer Therapies

9.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A computational rule-based model of MAPK/ERK system regulation.

Scientific reports·2026
Same author

A Neyman-Pearson Framework for Modeling Cellular Decision Making Using Single-Cell TNF-NF-κB Signaling Data.

bioRxiv : the preprint server for biology·2026
Same author

Quantifying cancer- and drug-induced changes in Shannon information capacity of RTK signaling.

Scientific reports·2025
Same author

Quantifying cancer- and drug-induced changes in Shannon information capacity of RTK signaling.

bioRxiv : the preprint server for biology·2025
Same author

Information transmission in a cell monolayer: A numerical study.

PLoS computational biology·2025
Same author

Single-Cell Measurements and Modeling and Computation of Decision-Making Errors in a Molecular Signaling System with Two Output Molecules.

Biology·2023

Related Experiment Video

Updated: Dec 13, 2025

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.6K

Model-based optimization of combination protocols for irradiation-insensitive cancers.

Beata Hat1, Joanna Jaruszewicz-Błońska1, Tomasz Lipniacki2

  • 1Institute of Fundamental Technological Research, Polish Academy of Sciences, Warsaw, Poland.

Scientific Reports
|July 30, 2020
PubMed
Summary

Combining targeted therapy with radiation can overcome cancer s resistance to radiation. Optimized protocols show potential for high cancer cell apoptosis with minimal normal cell damage.

More Related Videos

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.8K
Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

3.0K

Related Experiment Videos

Last Updated: Dec 13, 2025

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.6K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.8K
Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

3.0K

Area of Science:

  • Oncology
  • Radiation Oncology
  • Computational Biology

Background:

  • Cancer cells with wild-type p53 can develop resistance to radiation therapy due to alterations in the p53 regulatory network, such as downregulated PTEN or overexpressed Wip1.
  • Radiation monotherapy may be ineffective against these resistant cancer types.

Purpose of the Study:

  • To identify optimal combination protocols of targeted therapy and radiation for treating cancers resistant to radiation monotherapy.
  • To investigate the impact of timing and Mdm2 inhibitor dosage in combination therapy using a computational model.

Main Methods:

  • Utilized a stochastic computational model of the p53 regulatory network to simulate cell apoptosis.
  • Evaluated combination protocols with varying irradiation intervals (12, 18, 24, 36 hours) and Mdm2 inhibitor delivery schedules.
  • Incorporated assumptions of higher inhibitor uptake and irradiation dose in cancer cells compared to neighboring normal cells.

Main Results:

  • The timing of Mdm2 inhibitor administration relative to irradiation significantly affects apoptotic fractions in both normal and cancer cells.
  • Protocols with irradiation repeated every 24 or 36 hours, combined with two Mdm2 inhibitor doses per cycle, were most effective.
  • These optimized protocols achieved >95% cancer cell apoptosis while sparing <10% of normal cells.

Conclusions:

  • Combination therapy, specifically timed Mdm2 inhibition with fractionated radiation, can overcome radiation resistance in p53 wild-type cancers.
  • The computational model successfully identified treatment strategies that maximize cancer cell death and minimize toxicity to surrounding normal tissues.
  • These findings support the development of novel therapeutic strategies for radioresistant cancers.